FY25 consensus $21.04. Raises FY25 revenue view to $35.8B-$36.6B from $35B-$36B, consensus $35.66B. Sees FY25 capital expenditures in the range of $2.2B-$2.3B. Share repurchases not to exceed $500M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMGN:
- Notable companies reporting after market close
- These Are the Stocks Reporting Earnings Today – November 4, 2025
- Closing Bell Movers: Palantir down 3% after earnings
- AMGN Earnings this Week: How Will it Perform?
- Amgen’s Promising Phase 3 Study on Blinatumomab for Leukemia: What Investors Need to Know